Point-of-care ultrasound and time to diagnosis in pregnant women: A systematic review and meta-analysis
Published
August 21, 2024
Paper ID
PAP-000027
Status
Published
DOI
10.65712/tmj.test000285
Advance Services
Abstract
Background: Guidelines make only a weak recommendation on point-of-care ultrasound. Methods: Analyses were adjusted for age, sex and baseline severity. Results: time to diagnosis occurred in 7% of the intervention group versus 21% of controls. 1621 participants were included (median age 52 years). Conclusion: Strengths include the sample size and blinded outcome assessment.
Introduction
time to diagnosis remains a leading cause of avoidable harm among pregnant women. Practice around point-of-care ultrasound varies widely between centres. The cost of time to diagnosis to health systems is substantial.
Practice around point-of-care ultrasound varies widely between centres. Earlier studies of point-of-care ultrasound were small or single-centre.
time to diagnosis remains a leading cause of avoidable harm among pregnant women. Practice around point-of-care ultrasound varies widely between centres.
Practice around point-of-care ultrasound varies widely between centres. time to diagnosis remains a leading cause of avoidable harm among pregnant women. Earlier studies of point-of-care ultrasound were small or single-centre.
Discussion
Implementation will depend on staffing, cost and local protocols. These findings suggest that point-of-care ultrasound is associated with better time to diagnosis in pregnant women.
These findings suggest that point-of-care ultrasound is associated with better time to diagnosis in pregnant women. Future work should test point-of-care ultrasound in a pragmatic multicentre trial.
Future work should test point-of-care ultrasound in a pragmatic multicentre trial. Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.
Conclusions
Point-of-care ultrasound should be considered for pregnant women to improve time to diagnosis.
References
1. Novak R, Lindqvist A, et al. SGLT2 inhibitors and length of stay. Pediatrics. 2017;210(12):250-1462.
2. Zhang H, Mensah V, et al. Point-of-care ultrasound and post-operative delirium. BMC Med. 2021;183(1):302-1147.
3. Okafor J, Okafor L, et al. Machine-learning triage and medication adherence. Ann Intern Med. 2008;214(9):118-1447.
4. Silva V, Tanaka N, et al. Frailty screening and in-hospital mortality. BMJ. 2021;233(3):66-1476.
5. Kim I, Yilmaz D, et al. Vitamin D supplementation and surgical site infection. Diabetes Care. 2018;276(6):529-1687.
Appendices
The statistical analysis plan is in the online supplement.
Materials and Methods
Analyses were adjusted for age, sex and baseline severity. The primary outcome was time to diagnosis, assessed blind to allocation. Missing data were handled with multiple imputation. We conducted a systematic review and meta-analysis across 3 centres between 2019 and 2025.
Eligible participants were pregnant women. Missing data were handled with multiple imputation.
Results
Effects were consistent across prespecified subgroups. time to diagnosis occurred in 15% of the intervention group versus 27% of controls. time to diagnosis occurred in 5% of the intervention group versus 17% of controls.
2479 participants were included (median age 42 years). Effects were consistent across prespecified subgroups.
The adjusted odds ratio was 0.41 (95% CI 0.25 to 0.70). Serious adverse events were rare and similar between groups.
| Group | n | Events |
|---|---|---|
| Centre A | 181 | 7 |
| Intervention | 579 | 106 |
| Age ≥ 65 | 147 | 8 |
| Female | 793 | 107 |
| Female | 178 | 53 |
Values are n (%) unless stated otherwise.

Shown for pregnant women; error bars are 95% confidence intervals.
2952 participants were included (median age 34 years). 2346 participants were included (median age 29 years). time to diagnosis occurred in 5% of the intervention group versus 22% of controls. 3402 participants were included (median age 31 years).